Literature DB >> 9034218

Tensioactivity and supramolecular organization of the palmitoyl prodrug of timolol.

B Pech1, J E Proust, Y Bouligand, J P Benoit.   

Abstract

PURPOSE: To improve the bioavailability of the ocular drug timolol by facilitating its transport through the cornea, an amphiphilic prodrug was synthesized via the addition of a palmitic chain by esterification. The present study was undertaken to investigate the physicochemical and tensioactive properties of the prodrug.
METHODS: The amphiphilic properties of the prodrug were firstly investigated by the Wilhelmy plate method. The textures generated by the supramolecular organizations of the ester were visualized by optical microscopy.
RESULTS: The prodrug clearly decreased the surface tension. Optical microscopy provided excellent evidence for the existence of lyotropic liquid crystalline phases: two isotropic but organized phases and a birefringent lamellar phase.
CONCLUSIONS: The results from the ensemble of studies undertaken to determine the amphiphilic properties of the prodrug were all in accord with its ability to form liquid crystalline phases. The liquid crystalline state of the prodrug is believed to introduce a delay in the drug pharmacological effect.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034218     DOI: 10.1023/a:1012047231989

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

Review 1.  Topical ocular drug delivery: recent developments and future challenges.

Authors:  V H Lee; J R Robinson
Journal:  J Ocul Pharmacol       Date:  1986

2.  Pharmacosomes--a novel drug delivery system.

Authors:  M O Vaizoglu; P P Speiser
Journal:  Acta Pharm Suec       Date:  1986

3.  Improving the therapeutic index of topically applied ocular drugs.

Authors:  T J Zimmerman; K S Kooner; A S Kandarakis; L P Ziegler
Journal:  Arch Ophthalmol       Date:  1984-04

4.  Adverse reactions from timolol administration.

Authors:  E M Van Buskirk
Journal:  Ophthalmology       Date:  1980-05       Impact factor: 12.079

5.  Preliminary evaluation of a series of amphiphilic timolol prodrugs: possible evidence for transscleral absorption.

Authors:  B Pech; P Chetoni; M F Saettone; O Duval; J P Benoit
Journal:  J Ocul Pharmacol       Date:  1993

6.  Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985.

Authors:  W L Nelson; F T Fraunfelder; J M Sills; J B Arrowsmith; J N Kuritsky
Journal:  Am J Ophthalmol       Date:  1986-11-15       Impact factor: 5.258

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.